Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Jul 11, 2022

SELL
$72.62 - $79.98 $1.87 Million - $2.06 Million
-25,700 Closed
0 $0
Q1 2022

Apr 25, 2022

BUY
$61.48 - $73.72 $1.58 Million - $1.89 Million
25,700 New
25,700 $1.67 Million
Q2 2021

Jul 21, 2021

SELL
$61.91 - $67.42 $167,157 - $182,034
-2,700 Closed
0 $0
Q1 2021

Apr 23, 2021

SELL
$59.34 - $66.74 $640,872 - $720,792
-10,800 Reduced 80.0%
2,700 $162,000
Q4 2020

Jan 27, 2021

BUY
$57.74 - $65.43 $664,010 - $752,445
11,500 Added 575.0%
13,500 $836,000
Q3 2020

Oct 26, 2020

SELL
$57.43 - $63.64 $1.05 Million - $1.16 Million
-18,300 Reduced 90.15%
2,000 $122,000
Q3 2019

Oct 24, 2019

BUY
$42.77 - $50.71 $868,231 - $1.03 Million
20,300 New
20,300 $76,000
Q1 2019

Apr 29, 2019

SELL
$45.12 - $53.8 $3.19 Million - $3.8 Million
-70,700 Closed
0 $0
Q4 2018

Jan 16, 2019

SELL
$48.76 - $63.23 $126,776 - $164,398
-2,600 Reduced 3.55%
70,700 $121,000
Q3 2018

Oct 15, 2018

BUY
$55.19 - $62.25 $3.77 Million - $4.25 Million
68,300 Added 1366.0%
73,300 $190,000
Q2 2018

Jul 09, 2018

BUY
$50.53 - $62.98 $252,650 - $314,900
5,000 New
5,000 $4,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Center Star Asset Management, LLC Portfolio

Follow Center Star Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center Star Asset Management, LLC with notifications on news.